Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Anti-acne Cosmetics Market, by Product
1.4.2 Europe Anti-acne Cosmetics Market, by End Use
1.4.3 Europe Anti-acne Cosmetics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Anti-acne Cosmetics Market by Product
3.1 Europe Creams & Lotions Market by Country
3.2 Europe Cleanser & Toner Market by Country
3.3 Europe Mask Market by Country
3.4 Europe Other Products Market by Country
Chapter 4. Europe Anti-acne Cosmetics Market by End Use
4.1 Europe Women Market by Country
4.2 Europe Men Market by Country
Chapter 5. Europe Anti-acne Cosmetics Market by Country
5.1 Germany Anti-acne Cosmetics Market
5.1.1 Germany Anti-acne Cosmetics Market by Product
5.1.2 Germany Anti-acne Cosmetics Market by End Use
5.2 UK Anti-acne Cosmetics Market
5.2.1 UK Anti-acne Cosmetics Market by Product
5.2.2 UK Anti-acne Cosmetics Market by End Use
5.3 France Anti-acne Cosmetics Market
5.3.1 France Anti-acne Cosmetics Market by Product
5.3.2 France Anti-acne Cosmetics Market by End Use
5.4 Russia Anti-acne Cosmetics Market
5.4.1 Russia Anti-acne Cosmetics Market by Product
5.4.2 Russia Anti-acne Cosmetics Market by End Use
5.5 Spain Anti-acne Cosmetics Market
5.5.1 Spain Anti-acne Cosmetics Market by Product
5.5.2 Spain Anti-acne Cosmetics Market by End Use
5.6 Italy Anti-acne Cosmetics Market
5.6.1 Italy Anti-acne Cosmetics Market by Product
5.6.2 Italy Anti-acne Cosmetics Market by End Use
5.7 Rest of Europe Anti-acne Cosmetics Market
5.7.1 Rest of Europe Anti-acne Cosmetics Market by Product
5.7.2 Rest of Europe Anti-acne Cosmetics Market by End Use
Chapter 6. Company Profiles
6.1 Estee Lauder Companies, Inc. (Clinique)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.2 Unilever PLC (Murad Skincare)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Johnson and Johnson
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental &Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 L'Oreal Group
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Acquisition and Mergers:
6.4.5.2 Product Launches and Product Expansions:
6.5 LVMH SE
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Beiersdorf AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 KOSE Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.8 Rohto Pharmaceutical Co., Ltd. (Mentholatum)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research and Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.9 The Proactiv Company LLC (Guthy-Renker LLC)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Product Launches and Product Expansions:
6.9.2.2 Partnerships, Collaborations, and Agreements:
6.10. Ancalima Lifesciences Limited
6.10.1 Company Overview
Unique Offerings 
